Match!
Barri M. Blauvelt
University of Massachusetts Amherst
CancerNursingHepatocellular carcinomaFamily medicineMedicine
16Publications
7H-index
108Citations
What is this?
Publications 16
Newest
PurposeWomen with breast cancer in low- and middle-income countries (LMICs) have worse health outcomes than their counterparts in high-income countries (HICs). Improved outcomes in HICs are attributable to more rigorous breast cancer control policies, implementation of evidence-based guidelines, and greater national investment in health care. In resource-limited settings, identifying the most effective resource-appropriate policies can be a challenge. The proposed study will provide a framework ...
Source
Source
#1Douglas Bradford Mogul (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 5
#2Yusuke Nakamura (Johns Hopkins University)
Last. John F. P. Bridges (Johns Hopkins University)H-Index: 29
view all 5 authors...
ABSTRACTIntroduction: Celiac disease is an autoimmune disease that results from exposure to gluten in genetically susceptible individuals and leads to a range of gastrointestinal and extraintestinal symptoms. Areas covered: In order to evaluate the literature with respect to burden associated with celiac disease in the U.S. and identify any knowledge gaps, we performed a literature review of journal articles published between 2000–2016. We note that celiac disease is a prevalent condition associ...
Source
#1Susan M. Joy (Johns Hopkins University)H-Index: 8
#2Barri M. Blauvelt (UMass: University of Massachusetts Amherst)H-Index: 7
Last. John F. P. Bridges (Johns Hopkins University)H-Index: 29
view all 7 authors...
Background: As liver cancer incidence and mortality remain high in many parts of Europe, a more comprehensive response is required to reduce the burden. Expert stakeholders should be involved in the design of responses because they have important insights about potentially effective responses and will be affected by policy changes. We aimed to prioritize liver cancer control strategies based on European liver cancer stakeholders’ views of which strategies would have the greatest impact in a comp...
3 CitationsSource
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Susan M. Joy (Johns Hopkins University)H-Index: 8
Last. Barri M. Blauvelt (UMass: University of Massachusetts Amherst)H-Index: 7
view all 3 authors...
Source
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Liming Dong (Johns Hopkins University)H-Index: 1
Last. Timothy M. Pawlik (Johns Hopkins University)H-Index: 82
view all 6 authors...
Background Liver cancer is a complex and burdensome disease, with Asia accounting for 75% of known cases. Comprehensive cancer control requires the use of multiple strategies, but various stakeholders may have different views as to which strategies should have the highest priority. This study identified priorities across multiple strategies for comprehensive liver cancer control (CLCC) from the perspective of liver cancer clinical, policy, and advocacy stakeholders in China, Japan, South Korea a...
11 CitationsSource
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Susan M. Joy (Johns Hopkins University)H-Index: 8
Last. Timothy M. Pawlik (Johns Hopkins University)H-Index: 82
view all 6 authors...
Abstract In 2006, the European Parliament designated hepatocellular carcinoma (HCC) a serious public health problem, recognizing it as both a complex and deadly cancer. The authors conducted the first comparative needs assessment for HCC across five European countries. One hundred HCC experts assessed ten dimensions of HCC control. Common needs exist for lifestyle risk factor management (p < 0.001), political awareness (p < 0.001) and public awareness (p < 0.001). Discordances were found on fund...
8 CitationsSource
#1Gisselle Gallego (Johns Hopkins University)H-Index: 16
#2John F. P. Bridges (Johns Hopkins University)H-Index: 29
Last. Louis W. Niessen (Johns Hopkins University)H-Index: 31
view all 5 authors...
There is a growing need for efficient procedures for identification of emerging technologies by horizon scanning systems. We demonstrate the value of best-worst scaling (BWS) in exploring clinicians' views on emerging technologies that will impact outcomes in hepatocellular carcinoma (HCC) in the next 5 to 10 years.
20 CitationsSource
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Gisselle Gallego (Johns Hopkins University)H-Index: 16
Last. Barri M. Blauvelt (UMass: University of Massachusetts Amherst)H-Index: 7
view all 3 authors...
Background Liver cancer is the fifth most common cancer in men and the seventh for women. Usually because of late diagnosis, the prognosis for liver cancer remains poor, resulting in liver cancer being the third most common cause of death from cancer. While some countries have treatment guidelines, little is known or understood about the strategies needed for liver cancer control internationally.
10 CitationsSource
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Gisselle Gallego (Johns Hopkins University)H-Index: 16
Last. Barri M. Blauvelt (UMass: University of Massachusetts Amherst)H-Index: 7
view all 7 authors...
Liver cancer is both common and burdensome in Asia. Effective liver cancer control, however, is hindered by a complex etiology and a lack of coordination across clinical disciplines. We sought to identify strategies for inclusion in a comprehensive liver cancer control for Asia and to compare qualitative and quantitative methods for prioritization.
11 CitationsSource
12